We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$18.6B
AUM Growth
-$1.59B
Cap. Flow
-$881M
Cap. Flow %
-4.75%
Top 10 Hldgs %
25.83%
Holding
430
New
84
Increased
94
Reduced
203
Closed
27

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$241M
2
TWLO icon
Twilio
TWLO
+$60M
3
XYZ
Block Inc
XYZ
+$50.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$50M
5
SOFI icon
SoFi Technologies
SOFI
+$45.9M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$398M
2
ROKU icon
Roku
ROKU
+$137M
3
MTCH icon
Match Group
MTCH
+$117M
4
GS icon
Goldman Sachs
GS
+$107M
5
ENPH icon
Enphase Energy
ENPH
+$96M

Sector Composition

Rank Sector Weight
1 Technology 26.52%
2 Healthcare 23.41%
3 Consumer Discretionary 18.52%
4 Communication Services 12.03%
5 Miscellaneous 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
276
Boston Scientific
BSX
$65.3B
$802K ﹤0.01%
20,748
-30
-0.1% -$1.14K
TSHA icon
277
Taysha Gene Therapies
TSHA
$1.64B
$768K ﹤0.01%
37,824
-3,179
-8% -$86.1K
SMAR
278
DELISTED
Smartsheet Inc.
SMAR
$747K ﹤0.01%
11,683
-2,831
-20% -$198K
ETNB
279
DELISTED
89bio
ETNB
$732K ﹤0.01%
30,916
-983
-3% -$22.7K
PACB icon
280
Pacific Biosciences
PACB
$420M
$676K ﹤0.01%
20,306
-24,125
-54% -$844K
GDRX icon
281
GoodRx Holdings
GDRX
$1.21B
$643K ﹤0.01%
16,466
+486
+3% +$21.9K
SRPT icon
282
Sarepta Therapeutics
SRPT
$2.21B
$600K ﹤0.01%
8,049
-639,306
-99% -$59M
SPCE icon
283
Virgin Galactic
SPCE
$458M
$594K ﹤0.01%
970
-429
-31% -$323K
ZG icon
284
Zillow
ZG
$7.47B
$538K ﹤0.01%
4,092
-34
-0.8% -$5.25K
KRYS icon
285
Krystal Biotech
KRYS
$10.3B
$521K ﹤0.01%
6,769
-14
-0.2% -$1.02K
DAL icon
286
Delta Air Lines
DAL
$52.5B
$513K ﹤0.01%
10,632
+1,465
+16% +$64.8K
V icon
287
Visa
V
$701B
$499K ﹤0.01%
2,357
+718
+44% +$151K
OLO
288
DELISTED
Olo Inc
OLO
$489K ﹤0.01%
+18,523
New +$557K
STMP
289
DELISTED
Stamps.com, Inc.
STMP
$436K ﹤0.01%
2,186
+225
+11% +$48K
KBH icon
290
KB Home
KBH
$3.04B
$426K ﹤0.01%
9,154
+3,518
+62% +$145K
LNW
291
DELISTED
Light & Wonder
LNW
$419K ﹤0.01%
10,886
-6
-0.1% -$269
VINP icon
292
Vinci Compass Investments Ltd
VINP
$620M
$405K ﹤0.01%
+30,761
New +$499K
VXX icon
293
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$132M
$404K ﹤0.01%
553
-7,723
-93% -$7.72M
AGC
294
DELISTED
Altimeter Growth Corp
AGC
$390K ﹤0.01%
+33,315
New +$448K
GS icon
295
Goldman Sachs
GS
$288B
$389K ﹤0.01%
1,191
-344,221
-100% -$107M
XM
296
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$356K ﹤0.01%
+10,827
New +$439K
SILK
297
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$317K ﹤0.01%
6,261
-112,121
-95% -$6.23M
PCT icon
298
PureCycle Technologies
PCT
$1.18B
$315K ﹤0.01%
+12,370
New +$363K
ATEX icon
299
Anterix
ATEX
$1.52B
$303K ﹤0.01%
6,430
-2,888
-31% -$119K
RNAM
300
DELISTED
Avidity Biosciences
RNAM
$287K ﹤0.01%
13,156
+3,361
+34% +$82.3K
10 11
12
13 14

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Gilder Gagnon Howe & Co held 430 positions worth $18.6B, down 7.9% from $20.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $881M in Q1 2021, closing 27 positions and reducing 203 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Affirm worth $175M.

  • Gilder Gagnon Howe & Co's largest Q1 2021 buy was Affirm: 2,479,834 shares worth $175M.
  • Gilder Gagnon Howe & Co added most to Twilio in Q1 2021, an estimated $60M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2021 reduction was Tesla, cutting an estimated $398M.
  • Gilder Gagnon Howe & Co fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $43.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $18.6B portfolio in Q1 2021.
  • Gilder Gagnon Howe & Co opened 84 new positions and closed 27 in Q1 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 7.9% quarter-over-quarter to $18.6B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.